In our previous studies, we found that propranolol could reverse norepinephrine-induced tumor cell EMT through the modulation of β-AR/TGF-β1/HIF-1α/Snail and β-AR/TGF-β1/p-Smad3/Snail pathways (Zhang et al. 2016). This evidence concerns the gene HIF1A and neoplasm.